shortagewatch

Home / Digestive tract and metabolism / Cimetidine

ATC A02BA01 · H2-Receptor Antagonists

Cimetidine shortage

As of 2 Nov 2026, Cimetidine has a reported shortage in 2 of the 15 countries we track (Canada, Japan), covering 10 products from 5 companies.

Countries2/15
Products10packs or presentations
Companies51 listed
Short since23 Jan 201511.8 years ago
Earliest returnnot givencompany estimate
Main reasonActive ingredient shortage
United StatesNo reported shortageCanada4 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapan6 products shortAustraliaNo reported shortage

Timeline

CanadaJapan
20222023202420252026APO CIMETIDINE TAB 400MG (100 BTL & 500 BTL)APO CIMETIDINE TAB 400MG (100 BTL & 500 BTL)APO CIMETIDINE TAB 600MG (100 BTL)APO CIMETIDINE TAB 600MG (100 BTL)APO-CIMETIDINE ORAL SOLUTION (250 ML)APO-CIMETIDINE ORAL SOLUTION (250 ML)シメチジン錠200mg「クニヒロ」シメチジン錠200mg「クニヒロ」シメチジン錠400mg「クニヒロ」シメチジン錠400mg「クニヒロ」シメチジン細粒20%「ツルハラ」シメチジン細粒20%「ツルハラ」シメチジン錠200mg「ツルハラ」シメチジン錠200mg「ツルハラ」タガメット錠200mgタガメット錠200mgカイロック細粒40%カイロック細粒40%today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Apotex4皇漢堂製薬2Tsuruhara2Sumitomo Pharma1 4506藤本製薬1

Listed: Sumitomo Pharma 4506 · Tokyo

Compared with similar medicines

ATC group A02BA · H2-Receptor Antagonists
Famotidine4/15Cimetidine2/15Famotidine, Combinations1/15Lafutidine1/15Nizatidine1/15Ranitidine1/15Roxatidine1/15

Affected products

CountryProductCompanySinceExpected backReason
CAAPO CIMETIDINE TAB 400MG (100 BTL & 500 BTL)APOTEX INC23 Jan 2015not givenManufacturing problem
Disruption of the manufacture of the drug
CAAPO CIMETIDINE TAB 600MG (100 BTL)APOTEX INC23 Aug 2016not givenManufacturing problem
Disruption of the manufacture of the drug
CAAPO-CIMETIDINE ORAL SOLUTION (250 ML)APOTEX INC10 Mar 2017not givenManufacturing problem
Disruption of the manufacture of the drug
CAAPO CIMETIDINE TAB 300MG (1000 BTL) discontinuationAPOTEX INCnot givennot givenNot stated
シメチジン錠200mg「クニヒロ」 limited皇漢堂製薬4 Jul 2024not givenIncreased demand
シメチジン錠400mg「クニヒロ」 limited皇漢堂製薬4 Jul 2024not givenIncreased demand
シメチジン細粒20%「ツルハラ」鶴原製薬9 Sep 2024not givenActive ingredient shortage
Raw material (active ingredient) supply problem
シメチジン錠200mg「ツルハラ」鶴原製薬9 Sep 2024not givenActive ingredient shortage
Raw material (active ingredient) supply problem
タガメット錠200mg limited住友ファーマ7 Mar 2025not givenActive ingredient shortage
Raw material (active ingredient) supply problem
カイロック細粒40% limited藤本製薬20 May 2026not givenActive ingredient shortage
Raw material (active ingredient) supply problem

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.